| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $5.8M | — | +20.8% |
| Cost of Revenue | $1.5M | — | -40.6% |
| Gross Profit | $4.4M | — | +85.2% |
| R&D Expense | $38K | — | +39.6% |
| SG&A Expense | $3.1M | — | +637.5% |
| Operating Income | $731K | — | +240.5% |
| Pre-tax Income | $542K | — | +132.4% |
| Income Tax | $851K | — | +470.0% |
| Net Income | -$309K | — | -468.9% |
| EPS (Basic) | -$0.01 | — | -136.4% |
| EPS (Diluted) | -$0.01 | — | -136.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $29.7M | -10.1% | — |
| Accounts Receivable | $287 | +0.0% | — |
| Inventory | $851K | -11.0% | — |
| Current Assets | $31.4M | -15.0% | — |
| Total Assets | $39.1M | -12.5% | -46.9% |
| Current Liabilities | $19.0M | -22.7% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$3.6M | — | -779.5% |
| Capital Expenditures | $2K | — | -97.9% |
| Investing Cash Flow | -$2K | — | +97.4% |
| Financing Cash Flow | $116K | — | -75.4% |
| Free Cash Flow | -$3.6M | — | -646.2% |
| +466.5% |
| Total Liabilities | $19.2M | -22.7% | +226.9% |
| Stockholders' Equity | $19.9M | +0.1% | +510.3% |